<DOC>
	<DOCNO>NCT01455896</DOCNO>
	<brief_summary>Phase 3 study Evaluate cardiovascular outcome patient type 2 diabetes treat ITCA 650 .</brief_summary>
	<brief_title>A Study Evaluate Cardiovascular Outcomes Patients With Type 2 Diabetes Treated With ITCA 650</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>HBA1c &gt; 6.5 % History coronary , cerebrovascular peripheral artery disease history pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>